The global flow diverters market was valued at $251.4 million in 2021, and is projected to reach $1,041.9 million by 2031, registering a CAGR of 15.3% from 2022 to 2031. A cerebral or intracranial aneurysm is an abnormal focal dilation of an artery in the brain that results from a weakening of the inner muscular layer (the intima) of a blood vessel wall. For the treatment of cerebral aneurysms, flow diverters such as the surpass flow diverter, silk flow diverter, and pipeline embolization device. have been created. Instead of being implanted in the aneurysm sac, these endovascular devices are put inside the parent artery. They take advantage of altered hemodynamics at the aneurysm/parent vascular junction, which over time causes a progressive thrombosis of the aneurysm. The parent artery lumen is usually preserved together with perforators and side branches as a result of the subsequent inflammatory reaction, healing, and endothelial development that shrinks the aneurysm. Wide neck and massive aneurysms, which were previously incurable, can be treated by flow diverters.
The flow diverters market is driven by increase in the prevalence of cerebral or brain aneurysm, and rise in the prevalence of hypertension. Moreover, rise in the number of product launches and product approvals for flow diverters is anticipated to fuel the growth of flow diverters market. For instance, in August 2020, in the U. S., Stryker Corporation, medical equipment manufacturing company, announced the launch of Surpass Evolve Flow Diverter. It is a 64-wire cobalt chromium flow diverter designed for the treatment of unruptured giant and large wide-neck cerebral aneurysms. This approval is likely to help the company expand its neurovascular unit as well as its geographical presence. In addition, flow diverters are used to treat cerebral aneurysm, thus rise in the prevalence of cerebral aneurysm is anticipated to fuel the growth of the market. For instance, according to national institute of Neurological Disorders and Stroke, it was reported that, all cerebral aneurysms have the potential to rupture and cause bleeding within the brain or surrounding area. Approximately 30,000 Americans per year suffer a brain aneurysm rupture. Moreover, rise in the adoption of key strategies such as collaboration, acquisition, partnership and agreement by key players of flow diverters anticipated to fuel the growth of the market. In addition, technological advancement in the healthcare sector and increasing medical tourism are anticipated to drive the growth of flow diverters market. Moreover, rise in the awareness among the people regarding minimally invasive surgeries and increase in the disposable income among people in developing countries are anticipated to boost the growth of flow diverters market.
Geriatric population is more susceptible to orthopedic disorders, diabetes and fall injuries. These diseases causes rise in prevalence of pain. Thus, rise in number of geriatric populations increases the demand of flow diverters for treatment of cerebral aneurysm. Thus, this factor contributes to drive the growth of flow diverters market. In addition, Governments globally have increased the expenditure on the healthcare sector. For instance, according to the Centers for Medicare & Medicaid Services, the U. S. health care spending grew by 9.7% from 2019 to 2020, reaching $4.1 trillion ($12,530 per person). Similarly, as per the Office for National Statistics, total healthcare expenditure in the UK accounted for 12.8% of the gross domestic product (GDP) in 2020, compared to 10.2% in 2019. Furthermore, it has been estimated that approximately 30% of the healthcare expenditure is used in upgrading the healthcare infrastructure, especially medical equipment used at public health centers (hospitals). Hence, this rise in healthcare expenditure across the globe is expected to fuel the demand for in flow diverters application in different disease treatment, thereby boosting the market growth.
On the other hand, the side effects associated with flow diverters and high cost of flow diverters are anticipated to restrain the growth of the flow diverters market.
The global flow diverters market is segmented on the basis of type, application, end user and region. On the basis of type, the market is divided into pipeline embolization device, silk flow diverter, surpass flow diverter, flow redirection endoluminal device and others. Others include electrical muscle stimulation, silk flow diverter and interferential current therapy (IC) P64, Silk & PED, PED & FRED. On the basis of application, market is classified into cerebral aneurysms, multiple intracranial aneurysms and others. Multiple intracranial aneurysms segment is divided into ophthalmic artery, middle cerebral and posterior communicating artery. Others include large aneurysm, giant aneurysm, blister like, and fusiform aneurysm. On the basis of end user, the market is bifurcated into hospitals and clinics and ambulatory surgical center. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global flow diverters market include Acandis, BALT Extrusion SA, InspireMD, Johnson and Johnson, Medtronic, MicroPort Scientific Corporation, Microvention, Penumbra Inc., Phenox, Stryker Neurovascular.
The flow diverters market is driven by increase in the prevalence of cerebral or brain aneurysm, and rise in the prevalence of hypertension. Moreover, rise in the number of product launches and product approvals for flow diverters is anticipated to fuel the growth of flow diverters market. For instance, in August 2020, in the U. S., Stryker Corporation, medical equipment manufacturing company, announced the launch of Surpass Evolve Flow Diverter. It is a 64-wire cobalt chromium flow diverter designed for the treatment of unruptured giant and large wide-neck cerebral aneurysms. This approval is likely to help the company expand its neurovascular unit as well as its geographical presence. In addition, flow diverters are used to treat cerebral aneurysm, thus rise in the prevalence of cerebral aneurysm is anticipated to fuel the growth of the market. For instance, according to national institute of Neurological Disorders and Stroke, it was reported that, all cerebral aneurysms have the potential to rupture and cause bleeding within the brain or surrounding area. Approximately 30,000 Americans per year suffer a brain aneurysm rupture. Moreover, rise in the adoption of key strategies such as collaboration, acquisition, partnership and agreement by key players of flow diverters anticipated to fuel the growth of the market. In addition, technological advancement in the healthcare sector and increasing medical tourism are anticipated to drive the growth of flow diverters market. Moreover, rise in the awareness among the people regarding minimally invasive surgeries and increase in the disposable income among people in developing countries are anticipated to boost the growth of flow diverters market.
Geriatric population is more susceptible to orthopedic disorders, diabetes and fall injuries. These diseases causes rise in prevalence of pain. Thus, rise in number of geriatric populations increases the demand of flow diverters for treatment of cerebral aneurysm. Thus, this factor contributes to drive the growth of flow diverters market. In addition, Governments globally have increased the expenditure on the healthcare sector. For instance, according to the Centers for Medicare & Medicaid Services, the U. S. health care spending grew by 9.7% from 2019 to 2020, reaching $4.1 trillion ($12,530 per person). Similarly, as per the Office for National Statistics, total healthcare expenditure in the UK accounted for 12.8% of the gross domestic product (GDP) in 2020, compared to 10.2% in 2019. Furthermore, it has been estimated that approximately 30% of the healthcare expenditure is used in upgrading the healthcare infrastructure, especially medical equipment used at public health centers (hospitals). Hence, this rise in healthcare expenditure across the globe is expected to fuel the demand for in flow diverters application in different disease treatment, thereby boosting the market growth.
On the other hand, the side effects associated with flow diverters and high cost of flow diverters are anticipated to restrain the growth of the flow diverters market.
The global flow diverters market is segmented on the basis of type, application, end user and region. On the basis of type, the market is divided into pipeline embolization device, silk flow diverter, surpass flow diverter, flow redirection endoluminal device and others. Others include electrical muscle stimulation, silk flow diverter and interferential current therapy (IC) P64, Silk & PED, PED & FRED. On the basis of application, market is classified into cerebral aneurysms, multiple intracranial aneurysms and others. Multiple intracranial aneurysms segment is divided into ophthalmic artery, middle cerebral and posterior communicating artery. Others include large aneurysm, giant aneurysm, blister like, and fusiform aneurysm. On the basis of end user, the market is bifurcated into hospitals and clinics and ambulatory surgical center. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global flow diverters market include Acandis, BALT Extrusion SA, InspireMD, Johnson and Johnson, Medtronic, MicroPort Scientific Corporation, Microvention, Penumbra Inc., Phenox, Stryker Neurovascular.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the flow diverters market analysis from 2021 to 2031 to identify the prevailing flow diverters market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the flow diverters market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global flow diverters market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
- Pipeline embolization device
- Silk flow diverter
- Surpass flow diverter
- Flow redirection endoluminal device
- Others
By Application
- Others
- Cerebral aneurysms
- Multiple Intracranial Aneurysms
- Location
- Ophthalmic artery
- Middle cerebral
- Posterior communicating artery
By End User
- Hospital and clinics
- Ambulatory surgical center
By Region
- North America
- U. S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest Of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest Of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest Of LAMEA
Key Market Players
- Acandis
- BALT Extrusion SA
- Medtronic
- MicroPort Scientific Corporation
- Microvention
- Penumbra Inc.
- Phenox
- Stryker Neurovascular
- Phenox GmbH
- Johnson and Johnson
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
3.7. Patent Landscape
CHAPTER 4: FLOW DIVERTERS MARKET, BY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Pipeline embolization device
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Silk flow diverter
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Surpass flow diverter
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Flow redirection endoluminal device
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Others
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
CHAPTER 5: FLOW DIVERTERS MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Cerebral aneurysms
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Multiple Intracranial Aneurysms
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.3.4 Multiple Intracranial Aneurysms Flow Diverters Market by Location
5.3.4.1 Ophthalmic artery Market size and forecast, by region
5.3.4.2 Middle cerebral Market size and forecast, by region
5.3.4.3 Posterior communicating artery Market size and forecast, by region
5.4 Others
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: FLOW DIVERTERS MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospital and clinics
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Ambulatory surgical center
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
CHAPTER 7: FLOW DIVERTERS MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Type
7.2.3 North America Market size and forecast, by Application
7.2.3.1 North America Multiple Intracranial Aneurysms Flow Diverters Market by Location
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U. S.
7.2.5.1.1 Market size and forecast, by Type
7.2.5.1.2 Market size and forecast, by Application
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Type
7.2.5.2.2 Market size and forecast, by Application
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Type
7.2.5.3.2 Market size and forecast, by Application
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Type
7.3.3 Europe Market size and forecast, by Application
7.3.3.1 Europe Multiple Intracranial Aneurysms Flow Diverters Market by Location
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Type
7.3.5.1.2 Market size and forecast, by Application
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Type
7.3.5.2.2 Market size and forecast, by Application
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 UK
7.3.5.3.1 Market size and forecast, by Type
7.3.5.3.2 Market size and forecast, by Application
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Type
7.3.5.4.2 Market size and forecast, by Application
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Type
7.3.5.5.2 Market size and forecast, by Application
7.3.5.5.3 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Type
7.3.5.6.2 Market size and forecast, by Application
7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Type
7.4.3 Asia-Pacific Market size and forecast, by Application
7.4.3.1 Asia-Pacific Multiple Intracranial Aneurysms Flow Diverters Market by Location
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Market size and forecast, by Type
7.4.5.1.2 Market size and forecast, by Application
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 Japan
7.4.5.2.1 Market size and forecast, by Type
7.4.5.2.2 Market size and forecast, by Application
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Type
7.4.5.3.2 Market size and forecast, by Application
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 Australia
7.4.5.4.1 Market size and forecast, by Type
7.4.5.4.2 Market size and forecast, by Application
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Type
7.4.5.5.2 Market size and forecast, by Application
7.4.5.5.3 Market size and forecast, by End User
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Market size and forecast, by Type
7.4.5.6.2 Market size and forecast, by Application
7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Type
7.5.3 LAMEA Market size and forecast, by Application
7.5.3.1 LAMEA Multiple Intracranial Aneurysms Flow Diverters Market by Location
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Type
7.5.5.1.2 Market size and forecast, by Application
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Type
7.5.5.2.2 Market size and forecast, by Application
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Type
7.5.5.3.2 Market size and forecast, by Application
7.5.5.3.3 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Type
7.5.5.4.2 Market size and forecast, by Application
7.5.5.4.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Players
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Acandis
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 BALT Extrusion SA
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Medtronic
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 MicroPort Scientific Corporation
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Microvention
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Penumbra Inc.
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Phenox
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Stryker Neurovascular
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Phenox GmbH
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Johnson and Johnson
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
Executive Summary
According to this report, titled, 'Flow Diverters Market,' the flow diverters market size was valued at $251.50 million in 2021, and is projected to reach $1,041.90 million by 2031, growing at a CAGR of 15.3% from 2022 to 2031. A cerebral artery or vein wall weakness that results in a localized inflating of the blood vessel is referred to as an intracranial aneurysm, also known as a brain aneurysm. An endovascular device called a flow diverter is used to treat brain aneurysms. It is positioned in the aneurysm's parent artery, which covers the neck, to change the course of blood flow and monitor the sac's developing thrombosis. Flow-rerouting stents are made of flexible braids made of radiopaque wires woven together with structural Cobalt-chrome or Nitinol alloy wires.Factors that drive the flow diverters market trends include rise in number of flow diverters industry to manufacture flow diverters, rise in the research activities which enhances demand of flow diverters, and increase in number of medical device company. For instance, some of the key industry players operating in the flow diverters market include Acandis, BALT Extrusion SA, InspireMD, Johnson and Johnson, Medtronic, MicroPort Scientific Corporation, Microvention, Penumbra Inc., Phenox, Stryker Neurovascular.
Moreover, rise in the prevalence of hypertension is anticipated to fuel the growth of flow diverters market. It is understood that hypertension poses a significant risk for the emergence, growth, and rupture of cerebral aneurysms. High blood pressure can cause hemodynamic stress and inflammation, which can damage and enlarge the artery wall and cause a brain aneurysm to form and burst. Thus, increase in the prevalence of hypertension leads to rise in the prevalence of brain aneurysm. Thus, this factor is anticipated to fuel the demand for flow diverters. and drive the flow diverters market growth. For instance, in 2019, as per the report shared by WHO (World Health Organization), around 1.1 billion people worldwide were reported to have been suffering from hypertension.
In addition, increase in the number of product launch and product approval for flow diverters is anticipated to drive the growth of flow diverters market. For instance, in July 2020, Balt Extrusion, medical equipment manufacturing company, announced CE mark approval for its Silk Vista flow diverting stent used to treat small or medium-sized intracranial aneurysms (unruptured). This product will be commercialized in over 30 European Moreover, rise in the adoption of minimally invasive procedure for treatment of cerebral aneurysm drive the growth of flow diverters market.
Moreover, geriatric population is more susceptible to cerebral aneurysm. Thus, rising geriatric population is anticipated to increase in prevalence of cerebral aneurysm. Thus, this factor fuels the demand of flow diverters and drives the market growth. For instance, according to the World Health Organization (WHO) in October 2021, by 2030, 1 in 6 population in the world will be aged 60 years or over. Therefore, increase in the number of geriatric populations anticipated to boost the market growth.
On the basis of type, the market is classified into pipeline embolization device, silk flow diverter, surpass flow diverter, flow redirection endoluminal device and others. The pipeline embolization device segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to technological advancement in the development of flow diverters and wide of application of pipeline embolization device for treatment of cerebral aneurysm.
On the basis of application, the market is classified into cerebral aneurysms, multiple intracranial aneurysms and others. The Cerebral aneurysms segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to increase in the prevalence of hypertension and rising frequency of brain aneurysm.
On the basis of end user, the market is classified into hospitals and clinics and ambulatory surgical center. The hospitals and clinics segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to rise in the number of hospitals, increase in the expenditure by government to develop healthcare infrastructure and rise in the number of chronic diseases.
North America accounted for a majority of the global flow diverters market share in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to increase in the number of research activities, technological advancement in the healthcare sector and rise in the prevalence of chronic diseases. Asia-Pacific is anticipated to witness lucrative growth, owing to owing rise in expenditure by government organization to develop healthcare sector, increase in prevalence of chronic diseases and rise in the number of key players who manufactures flow diverters devices.
In addition, decline in the number of consultations of geriatric population, as geriatric population was more susceptible to COVID-19 infection also attributes to restrain the growth of flow diverters market. In addition, decreased disposable income and decline in consultations hinder the market growth. On the other hand, post pandemic impact of COVID-19 on flow diverters market is positive owing to rise in the number of consultations. Moreover, increase in research activities after pandemic foster positive impact on market. In addition, increase in the number of surgeries after the pandemic anticipated to have significant impact on flow diverters market.
Key Findings of The Study
By type, the pipeline embolization device stimulation segment was the highest contributor to the market in 2021.By application, the cerebral aneurysms segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
By end user, the hospitals and clinics segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
By region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- Acandis
- Balt Extrusion SA
- Medtronic
- Microport Scientific Corporation
- Microvention
- Penumbra Inc.
- Phenox
- Stryker Neurovascular
- Phenox GmbH
- Johnson and Johnson
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 301 |
| Published | October 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 251.4 million |
| Forecasted Market Value ( USD | $ 1041.9 million |
| Compound Annual Growth Rate | 15.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
